PNPLA6

Chr 19

patatin like domain 6, lysophospholipase

Also known as: BNHS, LNMS, NTE, NTEMND, OMCS, SPG39, iPLA2delta, sws

This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.64
Clinical SummaryPNPLA6
🧬
Gene-Disease Validity (ClinGen)
retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
126 unique Pathogenic / Likely Pathogenic· 555 VUS of 1523 total submissions
📖
GeneReview available — PNPLA6
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
0.64LOEUF
pLI 0.000
Z-score 4.00
OE 0.48 (0.360.64)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
4.35Z-score
OE missense 0.59 (0.550.64)
529 obs / 895.8 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.48 (0.360.64)
00.351.4
Missense OE?0.59 (0.550.64)
00.61.4
Synonymous OE?1.01
01.21.6
LoF obs/exp: 33 / 68.8Missense obs/exp: 529 / 895.8Syn Z: -0.15
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePNPLA6-related retinal dystrophy-ataxia-pituitary hormone abnormality-hypogonadism syndromeLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7034th %ile
GOF
0.75top 25%
LOF
0.3356th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

1523 submitted variants in ClinVar

Classification Summary

Pathogenic72
Likely Pathogenic54
VUS555
Likely Benign644
Benign89
Conflicting86
72
Pathogenic
54
Likely Pathogenic
555
VUS
644
Likely Benign
89
Benign
86
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
56
12
4
0
72
Likely Pathogenic
32
21
1
0
54
VUS
13
466
51
25
555
Likely Benign
0
9
304
331
644
Benign
0
2
82
5
89
Conflicting
86
Total1015104423611,500

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

6 pathogenic / likely-pathogenic (of 12) ClinVar copy-number / structural variants overlap PNPLA6 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PNPLA6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →